Skip to main content
. 2020 Oct 19;18:397. doi: 10.1186/s12967-020-02562-y

Table 5.

Blood analysis before and after rhEPO administration

Control n = 948 rhEPO n = 950 Difference (95% CI) P value
Before rhEPO administration
RBC count (× 1012/L), 4.0 ± 0.8 3.9 ± 0.6 0.06 (0.00–0.12) 0.065
 Hemoglobin (g/l) 139.5 ± 29.1 140.8 ± 27.6 1.30 (− 1.25–3.85) 0.318
 Hematocrit (%), 42.3 ± 8.8 42.7 ± 8.4 0.40 (− 0.37–1.17) 0.311
 Platelet (109/L 239.1 ± 114.2 246.1 ± 108.4 7.00 (− 3.02–17.02) 0.171
After rhEPO administration
 RBC count (1012/L) 3.0 ± 0.5 3.3 ± 0.5 0.30 (0.25–0.35)  < 0.001
 Hemoglobin (g/l), 98.2 ± 18.3 106.3 ± 23.6 8.10 (6.20–10.00)  < 0.001
 Hematocrit (%) 29.8 ± 5.5 32.2 ± 7.1 2.40 (1.83–2.97)  < 0.001
 Platelet (109/L) 265.3 ± 124.1 268.8 ± 109.7 3.50 (-7.04–14.04) 0.515
 Transfusions 1.8 ± 1.9 1.5 ± 1.7 0.302 (0.181–0.424)  < 0.001